SEC Form 4 · accession 0000899243-16-012748
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Feb 3, 2016
Accepted (ET)
Feb 5, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2016 | M | 34,722 | $3.42 | A | 43,595 | D | |
| Common StockF1 | holding | — | — | — | 95,194 | I | Langer Family Holdings, LLLP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $3.42 | Feb 3, 2016 | M | 34,722 | D | — | Sep 24, 2023 | Common Stock | 34,722 | 6,945 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.
- F21/36 vests on the last day of the month starting with a vesting start date of 07/30/2013.
Remarks
Exhibit 24.1 - Power of Attorney